Results 61 to 70 of about 3,800,890 (227)

Synergistic antibacterial effects of colistin in combination with aminoglycoside, carbapenems, cephalosporins, fluoroquinolones, tetracyclines, fosfomycin, and piperacillin on multidrug resistant Klebsiella pneumoniae isolates.

open access: yesPLoS ONE, 2021
Multidrug resistant Enterobacterales have become a serious global health problem, with extended hospital stay and increased mortality. Antibiotic monotherapy has been reported ineffective against most drug resistant bacteria including Klebsiella ...
Julalak C Ontong   +3 more
doaj   +1 more source

A chemical–genetic interaction map of small molecules using high‐throughput imaging in cancer cells

open access: yesMolecular Systems Biology, 2015
Small molecules often affect multiple targets, elicit off‐target effects, and induce genotype‐specific responses. Chemical genetics, the mapping of the genotype dependence of a small molecule's effects across a broad spectrum of phenotypes can identify ...
Marco Breinig   +3 more
doaj   +1 more source

Editorial: Gastrointestinal and Liver Effects of Fruits and Their Synergism With Drug Therapy: Exploring Possible Mechanisms of Action [PDF]

open access: gold, 2022
Almir Gonçalves Wanderley   +4 more
openalex   +1 more source

Drug Synergism of Anticancer Action in Combination with Favipiravir and Paclitaxel on Neuroblastoma Cells. [PDF]

open access: yesMedicina (Kaunas), 2023
Turkez H   +5 more
europepmc   +1 more source

Antimicrobial combination effects against multidrug‐resistant Acinetobacter baumannii and Pseudomonas aeruginosa strains: A cross‐sectional study

open access: yesHealth Science Reports
Background and Aims Emergence of multidrug resistance in non‐fermenting Gram‐negative bacilli is a threat to public health. Combination therapy is a strategy for the treatment of antibiotic‐resistant infections.
Hossein Kazemian   +4 more
doaj   +1 more source

Combination of HDAC and FYN inhibitors in synovial sarcoma treatment

open access: yesFrontiers in Cell and Developmental Biology
The SS18-SSX fusion protein is an oncogenic driver in synovial sarcoma. At the molecular level, SS18-SSX functions as both an activator and a repressor to coordinate transcription of different genes responsible for tumorigenesis.
Kyra Parker   +6 more
doaj   +1 more source

The Acquired Vulnerability Caused by CDK4/6 Inhibition Promotes Drug Synergism Between Oxaliplatin and Palbociclib in Cholangiocarcinoma. [PDF]

open access: yesFront Oncol, 2022
Suppramote O   +12 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy